Ultragenyx Pharma (RARE) PT Lowered to $140 at Truist Securities
Tweet
Share
E-mailGet Alerts RARE Hot Sheet
Price: $50.85 +2.50%
Rating Summary:
17 Buy, 5 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 16 | New: 24
Rating Summary:
17 Buy, 5 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 16 | New: 24
Join SI Premium – FREE
Truist Securities analyst Joon Lee lowered the price target on Ultragenyx Pharma (NASDAQ: RARE) to $140.00 (from $185.00) while maintaining a Buy rating.
You May Also Be Interested In
- Dollar General (DG) cut at Piper Sandler on 'inexplicable sales/comp weakness'
- Apollo Hospitals (APHS:IN) PT Raised to INR5,300 at Credit Suisse
- SMC Corp (6273:JP) (SMCAY) PT Raised to JPY87,000 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
